242 related articles for article (PubMed ID: 32891354)
1. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
O'Connell E; Reynolds IS; McNamara DA; Prehn JHM; Burke JP
Surg Oncol; 2020 Sep; 34():57-62. PubMed ID: 32891354
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study.
Lee JH; Kang BH; Song C; Kang SB; Lee HS; Lee KW; Chie EK; Kim JS
In Vivo; 2020; 34(4):2119-2126. PubMed ID: 32606192
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
Du C; Zhao J; Xue W; Dou F; Gu J
Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.
Hasan S; Renz P; Wegner RE; Finley G; Raj M; Monga D; McCormick J; Kirichenko A
Ann Surg; 2020 Apr; 271(4):716-723. PubMed ID: 30216221
[TBL] [Abstract][Full Text] [Related]
5. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer.
Bando H; Tsukada Y; Inamori K; Togashi Y; Koyama S; Kotani D; Fukuoka S; Yuki S; Komatsu Y; Homma S; Taketomi A; Uemura M; Kato T; Fukui M; Wakabayashi M; Nakamura N; Kojima M; Kawachi H; Kirsch R; Yoshida T; Suzuki Y; Sato A; Nishikawa H; Ito M; Yoshino T
Clin Cancer Res; 2022 Mar; 28(6):1136-1146. PubMed ID: 35063964
[TBL] [Abstract][Full Text] [Related]
7. Do microsatellite instability (MSI) and deficient mismatch repair (dMMR) affect the pathologic complete response (pCR) in patients with rectal cancer who received neoadjuvant treatment?
Acar T; Acar N; Kamer E; Tekindal MA; Cengiz F; Kar H; Atahan K; Haciyanli M
Updates Surg; 2020 Mar; 72(1):73-82. PubMed ID: 31863279
[TBL] [Abstract][Full Text] [Related]
8. Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.
Trojan J; Stintzing S; Haase O; Koch C; Ziegler P; Demes M; Jelas I
Oncologist; 2021 Dec; 26(12):e2110-e2114. PubMed ID: 34431576
[TBL] [Abstract][Full Text] [Related]
9. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
Seo I; Lee HW; Byun SJ; Park JY; Min H; Lee SH; Lee JS; Kim S; Bae SU
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692216
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.
Yoon G; Lee H; Kim JH; Hur K; Seo AN
Tumour Biol; 2016 Aug; 37(8):10209-18. PubMed ID: 26831663
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
[TBL] [Abstract][Full Text] [Related]
13. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
[TBL] [Abstract][Full Text] [Related]
14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
15. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
[TBL] [Abstract][Full Text] [Related]
16. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis.
Mechera R; Schuster T; Rosenberg R; Speich B
Eur J Cancer; 2017 Feb; 72():84-94. PubMed ID: 28027520
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
[TBL] [Abstract][Full Text] [Related]
19. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
[TBL] [Abstract][Full Text] [Related]
20. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
